KIDRON NADAV (CIK 1351779) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-31). Recent activity: Sell ORMP (44,818 shares), Buy LFWD (7,657 shares), Buy ORMP (167,005 shares), Sell ORMP (100,000 shares), Buy ORMP (109,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-31 | ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO | Sell | 44,818 | $148,348 |
| 2026-03-27 | Lifeward Ltd. (LFWD) | Director | Buy | 7,657 | $0 |
| 2026-03-18 | ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO | Buy | 167,005 | $0 |
| 2026-03-16 | ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO | Sell | 100,000 | $0 |
| 2026-01-29 | ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO | Buy | 109,000 | $0 |
| 2026-01-05 | ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO | Buy | 232,640 | $0 |
| 2026-01-05 | ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO | Buy | 327,000 | $0 |
| 2025-02-11 | ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO | Buy | 141,000 | $0 |
| 2025-02-11 | ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO | Buy | 186,000 | $0 |
| 2025-02-11 | ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO | Buy | 100,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-31